openPR Logo
Press release

Global Fluorescent In Situ Hybridization Probe Market 2014-2025: In-depth Industry Analysis Focusing on Top Key Players| Abbott Laboratories, Agilent Technologies, Thermo Fischer, Inc.

09-28-2018 07:47 AM CET | Health & Medicine

Press release from: AnalystView Market Insights

Global Fluorescent In Situ Hybridization Probe Market

AnalystView Market Insights has announced the addition of the “Global FISH Probe Industry Analysis and Opportunity Assessment 2014 – 2025” The global market is expected to grow at growth rate of 8.3% to reach USD 1.58 billion by 2025. The report analyzes the industry in terms of RNA type, end-use, application and regions. This comprehensive study reveals the market estimate numbers for different market segments. Along with that, the study covers qualitative insights, strategic benchmarking and thorough competitive landscaping in the report spreading over 144 pages.

FISH techniques are characterized by its ability to interpret required information at the genome level. This technique is being utilized over the past many decades for the identification of various chronic diseases and in signifying accurate and proper treatment options to the physicians. Increasing number of cancer patients is likely to boost the market growth. As per the statistics released by the National Cancer Institute, in 2016, it was estimated that 1,685,210 new cases of cancer will be diagnosed and 595,650 cancer deaths are anticipated to occur.

To request free sample copy:
www.analystviewmarketinsights.com/request_sample/av102/

Additionally, technological advancements supported the market demand. For instance, Silver ISH (SISH) assay technology, a type of CISH, is one of the emerging technologies in the market. Ventana Medical System introduced the “INFORM HER2 SISH DNA Probe Assay” to detect HER2 gene in breast cancer patients, exclusively in the U.S. SISH is a fully automated method of prenatal cancer diagnostics that saves time by offering faster and consistent results during clinical trials. Other factors such as the rise in research activities, favourable government initiatives, and others supported the market growth.

The global FISH probe market is segmented in terms of RNA types, end use, application, and technology. In terms of end use, the market is divided into clinical, research and companion diagnostics. mRNA AND miRNA are the types of RNA segment. Whereas, application segment is categorized into cancer and genetic diseases diagnostics. Cancer segment has been developing at a double-digit growth rate over the forecast period. Most widely known FISH cancer probe tests are the HER2 test for the detection of breast cancer and the UroVysion for detection of bladder cancer test (Abbott Laboratories). Geographically, Asia Pacific region is anticipated to grow with the highest CAGR during the forecast period owing to the constant support from the government for market development. Currently, in June 2017, the Global Health Innovative Technology Fund (GHIT) announced to provide USD 200 Million to the Japanese government for R&D in the healthcare industry.

GHIT aims to strengthen its collaboration with Japanese health organizations, such as Japan Agency for Medical Research and Development (AMED), Japan’s Pharmaceutical and Medical Devices Agency (PMDA), Japan International Cooperation Agency (JICA), and other major healthcare companies such as Fujifilm to bring innovations in the field of in-vitro diagnostics. Such initiatives are believed to augment the market growth to great extent. The market is highly competitive. Limited number of players have a significant dominance over the overall revenue share. The most notable market participants are Abbott Laboratories, Agilent Technologies, Life Science Technologies, accounted for a considerable share of the market owing to their wide range product offerings to the market. Market leaders are involved in extensive research for technologically advanced products and enhancement of distribution channels.

Browse full report with in-depth ToC on “Fluorescent In Situ Hybridization Probe (FISH Probe) Market Analysis By End Use (Clinical, Research, Companion Diagnostics), By Type Of RNA (mRNA, miRNA), By Application, And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at
www.analystviewmarketinsights.com/report-highlight-fluorescent-in-situ-hybridization-probe-fish-market-102/

Scope of the Report:
Market, by End Use: Clinical, Research and Companion Diagnostics;

Market, by RNA Type: mRNA and miRNA;

Market, by Application: Cancer Diagnostics and Genetic Diseases;

Market, by Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa and Rest of the World; Market, by Country: U.S., Canada, Germany, France, India, and China;

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
BioDot Inc.
Sigma Aldrich
Abnova
Abbott Laboratories
Agilent Technologies
Thermo Fischer, Inc.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Find out more by getting in touch: https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Fluorescent In Situ Hybridization Probe Market 2014-2025: In-depth Industry Analysis Focusing on Top Key Players| Abbott Laboratories, Agilent Technologies, Thermo Fischer, Inc. here

News-ID: 1268539 • Views:

More Releases from AnalystView Market Insights

Electric Vehicle Charging Stations Market : New Developments helps to grow market opportunities & forecast until 2026
Electric Vehicle Charging Stations Market : New Developments helps to grow marke …
According to latest study by AnalystView Market Insights provides the current status, and projected growth over the next five to ten years. Key topics addressed include market dynamics of the global Electric Vehicle Charging Stations market, projected industry revenue, average product pricing, among others.  With industry-standard accuracy in analysis and high data integrity, the reports from AnalystView Market Insights make a brilliant attempt to unveil key opportunities available to help
Radio Frequency Identification Technology Market Size, Share, Trend, Opportunity Assessment and Global Forecast to 2025 | Top Key Players; Atmel, Accenture and 3M
Radio Frequency Identification Technology Market Size, Share, Trend, Opportunity …
AnalystView Market Insights recently introduced an in-depth study on Global Radio Frequency Identification Technology market, describing different products and application area which elaborates market outlook and status to 2025. According to this study, by the end of 2025, the global Radio Frequency Identification Technology market is anticipated to reach USD 41.6 billion, growing at the growth rate of 15.1%. This proposed study provides a comprehensive analysis of radio frequency identification technology
Proteomics Market Research Report; Explores Market Trends, Size and Future Growth Prospect Until 2025
Proteomics Market Research Report; Explores Market Trends, Size and Future Growt …
New in-depth comprehensive study on “Global Proteomics Market” report has been added AnalystView’s report store. The report aims to describe about different products, application and technology which elaborates market outlook and status to 2025. According to this study, the global Proteomics market is expected to grow at growth rate of 10.2% to reach USD 25.3 billion by 2025.This proposed study provides comprehensive analysis based on industry’s growth potential, market drivers, barriers,
Global Industrial Robotics Market: Articulated Robots Continue to Hold a Major Share of Industry Revenue
Global Industrial Robotics Market: Articulated Robots Continue to Hold a Major S …
According to this study, Industrial Robotics market size to keep up the strong yearly development rate of 5.3% from USD 32.7 billion in 2017 to 2025. Trust that in the following couple of years, the industry’s showcase size will be extended, we expect that the market size will achieve 49.8 billion by the end of 2025. This industry analysis is a cumulative effort of paid primary interviews through paid data

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and